Jade Schiffman MD
Neuro-Ophthalmology
President, Neuro-Eye Clinical Trials Inc. Co-Director, Neuro-ophthlamology of Texas Adjunct Professor, Dept of Clinical Sciences, University of Houston, College of Medicine President, Neuro-Eye Diagnostic Systems, LLC Past Professor Ophthalmology and Neuro-oncology, University of Texas MD Anderson Cancer Center
Join to View Full Profile
Neuro-Eye Clinical Trials Inc.7500 Beechnut St. Suite 175Houston, TX 77074
Phone+1 281-701-0577
Fax+1 832-787-0142
Dr. Schiffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Letterman Army Medical CenterResidency, Ophthalmology, 1986 - 1989
University of California (San Francisco) School of MedicineFellowship, Neuro-Ophthalmology With Dr. William F. Hoyt, 1980 - 1981
University of Miami/Jackson Health SystemResidency, Neurology, 1977 - 1980
Baylor College of MedicineInternship, Internal Medicine, 1975 - 1976
SUNY Upstate Medical UniversityClass of 1975, MD
Certifications & Licensure
FL State Medical License 1978 - 2027
CA State Medical License 1980 - 2025
TX State Medical License 1976 - 2025
American Board of Ophthalmology Ophthalmology
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Best Doctors in America Best Doctors, 1994-2022
- Fellow (FAAN) American Academy of Neurology
- Fellow North American Neuro-ophthalmology Society
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsThyroid dermopathy responds to teprotumumab therapy.Ricaurte Crespo-Trevino, Jade Schiffman, Shoaib Ugradar, Kimberly Cockerham, Raymond Douglas
Endocrinology, Diabetes & Metabolism Case Reports. 2022-03-01 - 75 citationsTeprotumumab Efficacy, Safety and Durability in Longer Duration Thyroid Eye Disease and Retreatment: Optic-X StudyRaymond S Douglas, George J. Kahaly, Shoaib Ugradar, Heike M. Elflein, Katharina A. Ponto
Ophthalmology. 2021-10-21 - 24 citationsTeprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators.Raymond S Douglas, Yao Wang, Roger A. Dailey, Gerald J. Harris, Sara T. Wester
Journal of Neuro-Ophthalmology. 2021-01-04
Press Mentions
NASA Technology to Help Eye Patients on EarthJuly 5th, 2017
Research History
- Principal Investigator, Coinvestigator and CollabaratorSee CV with multiple research projects
Professional Memberships
- Member
- Member
- Fellow
- North American Neuro-ophthlamology SocietyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
